ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Please note that you are viewing an archived section from 2022 and some content may be unavailable. To unlock all content for 2022, please visit the archives.

Abstract: FR-PO114

Identifying Key Challenges and Opportunities in the Care of AKI Survivors Not on Dialysis: AKINow Workgroup

Session Information

Category: Acute Kidney Injury

  • 102 AKI: Clinical‚ Outcomes‚ and Trials


  • Abdel-Rahman, Emaad M., UVA Health, Charlottesville, Virginia, United States
  • Silver, Samuel A., Queens University, Kingston, Ontario, Canada
  • Barreto, Erin F., Mayo Clinic Minnesota, Rochester, Minnesota, United States
  • Cerda, Jorge, Albany Medical College, Albany, New York, United States
  • Gewin, Leslie S., Washington University in St Louis, St Louis, Missouri, United States
  • Neyra, Javier A., University of Kentucky, Lexington, Kentucky, United States
  • Ng, Jia Hwei, Northwell Health, Glen Cove, New York, United States
  • Vijayan, Anitha, Washington University in St Louis, St Louis, Missouri, United States

ASN recently established the AKINow initiative aiming to promote excellence in the prevention and treatment of AKI. One of the core policy, practice and research objectives of this workgroup is to identify gaps in the care of AKI survivors post hospitalization and develop quality evidence and benchmark existing strategies to care for these patients including insights from other stakeholders


We held a focus group with key stakeholders that included nephrologists, primary care providers, advanced practice providers (APP), intensivists, pediatric providers, community providers, patients and allied health personnel. We sought perspectives on optimal plans for hospital discharge of AKI survivors, challenges and opportunities in their care, communication strategies across diverse stakeholders, patient and care partner education and activation, and preferred interventions


While 54% of the participants (n=57) identified integrated care delivery among providers to be the biggest barrier for care of AKI survivors, 23% thought that education and awareness among patients are the main challenge. 79% of the participants recommended RAAS blockers resumption should be after serum creatinine returns to baseline/ new baseline. They further suggested that currently 95% of the care of AKI survivors is shouldered by nephrologists. This care is shared by Internists (51%), pharmacists (51%), RN (43%), APP (43%) and by other allied health personnel (8-22%). AKI patients’ survivor testimonial about their experiences highlighted some of the gaps encountered in their care. Four breakout sessions (12-15/session) suggested specific recommendations to inform who is currently followed after AKI and by whom, different options for care delivery, and potential interventions/practices that may improve clinical and patient-centered outcomes


The stakeholder relationships formed, including those with patients, industry, and academia, will facilitate a collaborative research and practice agenda to advise the best and efficient practices after AKI. This represents an opportunity for the “recovery after AKI” workgroup of AKINow to provide leadership by raising awareness and promoting strategies focused on equitable and effective post-AKI care throughout the ASN and wider nephrology community